Andlauer Healthcare Group Inc.
AND.TOTSXIndustrials
$54.97
+$0.00(+0.00%)
Market Cap$2.2B
P/E Ratio—
52W High$55.1
52W Low$36.68
Andlauer Healthcare Group Inc.（AND.TO）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AND.TO · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.06B | $0.07B | $0.08B | $0.09B | $0.04B |
| Depreciation & Amort. | $0.07B | $0.07B | $0.06B | $0.04B | $0.03B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.01B) | ($0.03B) | ($0.00B) | ($0.01B) | ($0.01B) |
| Net Cash from Operations | $0.12B | $0.10B | $0.14B | $0.08B | $0.05B |
| Investing Activities | |||||
| Capital Expenditure | ($0.02B) | ($0.03B) | ($0.03B) | ($0.01B) | ($0.01B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | ($0.01B) | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Net Cash from Investing | ($0.02B) | ($0.02B) | ($0.05B) | ($0.18B) | ($0.02B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.11B) | ($0.02B) | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.02B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Debt Issued / Repaid | ($0.00B) | ($0.05B) | ($0.03B) | $0.01B | ($0.02B) |
| Net Cash from Financing | ($0.13B) | ($0.09B) | ($0.05B) | $0.09B | ($0.02B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.10B | $0.08B | $0.11B | $0.07B | $0.05B |
| FCF Margin %(computed) | 15.99% | 12.17% | 16.84% | 16.91% | 14.50% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · CAD · B
深入了解Andlauer Healthcare Group Inc.
关于Andlauer Healthcare Group Inc.（AND.TO）现金流量表
Andlauer Healthcare Group Inc. 2024财年经营活动现金流$0.12B，自由现金流$0.10B（FCF利润率15.99%），资本支出($0.02B)。
常见问题
AND.TO · 4 问Andlauer Healthcare Group Inc. 2024财年自由现金流$0.10B，同比up32.0%。
AND.TO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10